chr3-158732382-A-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The ENST00000237696.10(RARRES1):c.34T>A(p.Trp12Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0036 in 1,501,498 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin ClinVar.
Frequency
Consequence
ENST00000237696.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RARRES1 | NM_206963.2 | c.34T>A | p.Trp12Arg | missense_variant | 1/6 | ENST00000237696.10 | NP_996846.1 | |
LOC100287290 | NR_171782.1 | n.22A>T | non_coding_transcript_exon_variant | 1/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RARRES1 | ENST00000237696.10 | c.34T>A | p.Trp12Arg | missense_variant | 1/6 | 1 | NM_206963.2 | ENSP00000237696 | P1 | |
ENST00000465477.5 | n.56A>T | non_coding_transcript_exon_variant | 1/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00269 AC: 408AN: 151950Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.00186 AC: 184AN: 98962Hom.: 0 AF XY: 0.00204 AC XY: 113AN XY: 55438
GnomAD4 exome AF: 0.00371 AC: 5003AN: 1349438Hom.: 16 Cov.: 41 AF XY: 0.00364 AC XY: 2421AN XY: 665468
GnomAD4 genome AF: 0.00268 AC: 408AN: 152060Hom.: 2 Cov.: 33 AF XY: 0.00250 AC XY: 186AN XY: 74358
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at